C

Co-Diagnostics
D

CODX

0.27700
USD
-0.02
(-5.23%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
9,338,371
أصول ذات صلة
A
AEMD
0.01000
(0.81%)
1.25000 USD
B
BNGO
-0.01000
(-0.30%)
3.37000 USD
I
IBIO
0.00500
(0.68%)
0.74000 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
L
LAKE
0.245
(1.80%)
13.855 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
N
NVAX
0.04000
(0.59%)
6.79000 USD
O
OPK
0.01500
(1.12%)
1.36000 USD
V
VIR
0.05500
(1.02%)
5.47000 USD
المزيد
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.